Aspirin overcomes cisplatin resistance in lung cancer by inhibiting cancer cell stemness
Aspirin overcomes cisplatin resistance in lung cancer by inhibiting cancer cell stemness Introduction Lung cancer is the leading cause of cancer death with a less than 20% five‐year survival rate.1 Resistance to clinical integrated treatment is reported as one major reason for treatment failure.2 The standard treatment of lung cancer is plain‐based combination chemotherapy.3 Cisplatin […]
Read More